Daikaffil Chemicals India Ltd.

BSE: DAIKAFFI530825ISIN INE789B01018

Commodities
Specialty Chemicals

BSE listing

Share price

₹45.96+0.41 (+0.90%)

as of 18 Sep 2026

52W high: ₹159.90
52W low: ₹28.48
Off 52W high: -71.26%
1M return: +20.79%
3M return: -12.21%
6M return: +4.98%
1Y return: -69.78%
20D avg volume: 4,891
50 DMA: ₹45.08
200 DMA: ₹50.40

Key ratios Consolidated

Market cap: ₹27.58 Cr
Current price: ₹45.96
52W high / low: ₹159.90 / ₹28.48
Face value: ₹10.00
P/E: -25.23
P/B: —
EPS (TTM): ₹-1.82
Book value / share: —
ROE: —
ROCE: -30.40%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-0.86 Cr
Interest cover: -225.00
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 83.4 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26
Income statement
	1.03	1.97	1.47
	0.01	0.02	0.01
	1.73	2.92	1.89
	1.14	1.23	0.33
	0.00	0.00	0.00
	0.42	0.45	0.46
	0.00	0.00	0.00
	0.08	0.10	0.09
	0.79	0.90	0.88
	-0.69	-0.93	-0.40
	0.00	0.00	0.00
	-0.69	-0.93	-0.40
	-0.01	0.00	-0.03
	-0.68	-0.93	-0.38
	-1.13	-1.54	-0.63
Key metrics
	-0.61	-0.83	-0.31
	-59.20%	-42.10%	-21.10%
	-66.00%	-47.20%	-25.90%
	—	-12.60%	—

Metric	FY26
Income statement
	13.35
	0.05
	15.66
	9.79
	0.00
	1.72
	0.01
	0.36
	3.86
	-2.26
	0.00
	-2.26
	-0.04
	-2.21
	-3.69
Key metrics
	-1.89
	-14.20%
	-16.60%
	-30.40%
	0.00
	-0.86
	83.4
Balance sheet
	9.42
	6.51
	0.86
	1.99
	2.66
	0.49
	2.08
	1.60
	2.01
	0.00
	0.00
	0.00
	6.78

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	1.03	1.97	1.47	6.04	3.88	4.00	—
	0.01	0.02	0.01	0.01	0.01	0.21	—
	1.67	2.88	1.85	7.39	3.47	4.49	—
	1.14	1.23	0.33	2.03	6.20	3.33	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.42	0.45	0.46	0.43	0.38	0.28	—
	0.00	0.00	0.00	0.00	0.01	0.00	—
	0.08	0.10	0.09	0.08	0.10	0.08	—
	0.74	0.86	0.84	0.96	1.13	1.40	—
	-0.64	-0.90	-0.37	-1.34	0.42	-0.28	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	-0.64	-0.90	-0.37	-1.34	0.42	-0.28	—
	-0.01	0.00	-0.03	0.00	0.00	0.07	—
	-0.63	-0.89	-0.34	-1.34	0.42	-0.35	—
	-1.05	-1.49	-0.56	-2.23	0.71	-0.58	—
Key metrics
	-0.56	-0.80	-0.28	-1.26	0.53	-0.20	—
	-54.40%	-40.60%	-19.00%	-20.90%	13.70%	-5.00%	—
	-61.20%	-45.20%	-23.10%	-22.20%	10.80%	-8.80%	—
	—	-12.20%	—	-15.70%	—	-3.00%	—
	-73.50%	-50.80%	—	—	—	—	—
	-250.00%	-154.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	10.51	13.35	7.50	—
	0.05	0.05	0.47	—
	13.79	15.58	9.57	—
	4.73	9.79	5.98	—
	0.00	0.00	0.00	—
	1.76	1.72	1.14	—
	0.00	0.01	0.00	—
	0.35	0.36	0.27	—
	3.40	3.79	3.12	—
	-3.25	-2.18	-1.60	—
	0.00	0.00	0.00	—
	-3.25	-2.18	-1.60	—
	-0.04	-0.04	-0.01	—
	-3.20	-2.14	-1.59	—
	-5.33	-3.57	-2.65	—
Key metrics
	-2.90	-1.81	-1.33	—
	-27.59%	-13.60%	-17.70%	—
	-30.45%	-16.00%	-21.20%	—
	—	-29.40%	-16.90%	—
	—	78.00%	—	—
	—	-34.60%	—	—
	—	0.55	-7.39	—
	—	-0.26	3.96	—
	—	0.00	0.00	—
	—	-0.57	-0.66	—
	—	83.4	223.9	—
Balance sheet
	—	9.69	14.41	—
	—	6.21	11.48	—
	—	0.57	0.66	—
	—	1.99	6.06	—
	—	2.66	3.25	—
	—	0.49	1.02	—
	—	2.08	1.96	—
	—	1.60	4.71	—
	—	2.32	4.97	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	6.74	8.85	—
Cash flow
	—	0.55	-6.30	—
	—	-0.64	-0.56	—
	—	0.00	0.00	—
	—	0.00	1.09	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 53.80%

Holder	Type	Holding	Previous	Change
Mikusu India Private Limited	Promoter	49.63%	—	—
Mahendra Girdharilal	Public	4.50%	—	—
Sams Industries Private Limited	Promoter Group	3.83%	—	—
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs	Public	3.04%	—	—
Sandeep Kapadia	Public	2.50%	—	—
Lincoln P Coelho	Public	1.67%	—	—
Pharma Synth Formulations Limited	Public	1.50%	—	—
Urvi Amit Chordia	Public	1.38%	—	—
World Foods LLP	Public	1.10%	—	—
Nithyanand K Shetty	Promoter Group	0.17%	—	—
Raghuram Kanyan Shetty	Promoter Group	0.17%	—	—
HERANBA INDUSTRIES LIMITED	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Enclosed herewith Newspaper Advertisement for publication of Notice of 34th Annual General Meeting of the Company .28 Aug 2026 · Company Update / Newspaper Publication
Intimation regarding letter sent to the Shareholders of the Company.27 Aug 2026 · Company Update / General
The Register of members and Share Transfer books of the company will remain closed from September 16, 2026 to September 22, 2026 (both days inclusive).27 Aug 2026 · Corp. Action / Book Closure
Enclosed herewith Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.27 Aug 2026 · Others / Reg. 34 (1) Annual Report
Enclosed herewith Notice of the 34th Annual General Meeting (AGM) Of The Company.27 Aug 2026 · AGM/EGM / AGM
Enclosed herewith Newspaper Advertisement for publication of Notice of 34th Annual General Meeting of the Company.26 Aug 2026 · Company Update / Newspaper Publication
Enclosed herewith Newspaper Publication of Un-audited Financial Results for the quarter ended June 30, 2026.17 Aug 2026 · Company Update / Newspaper Publication
Enclosed herewith Unaudited Financial Results for the quater ended on June 30, 2026.14 Aug 2026 · Result / Financial Results
Enclosed herewith Outcome of the Board Meeting.14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Daikaffil Chemicals India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Unaudited ....5 Aug 2026 · Board Meeting / Board Meeting
Enclosed herewith Newspaper Publication.16 Jul 2026 · Company Update / Newspaper Publication
Enclosed herewith Revised Consolidated Financial Results for the quater and year ended on March 31, 2026.14 Jul 2026 · Result / Financial Results
Enclosed herewith Outcome of Board Meeting.14 Jul 2026 · Board Meeting / Outcome of Board Meeting
Please find enclosed herewith, Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended June 30, 2026.9 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Daikaffil Chemicals India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/07/2026 ,inter alia, to consider and approve the revised financial ....9 Jul 2026 · Board Meeting / Board Meeting
We are enclosing herewith, the intimation of Closure of Trading Window for the Quarter ended June 30, 2026.25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 13,139 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details ....17 Jun 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mikusu India Pvt Ltd17 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mikusu India Pvt Ltd16 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 5,040 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details of ....16 Jun 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mikusu India Pvt Ltd15 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 3700 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details of ....13 Jun 2026 · Company Update / General
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 8,144 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details of ....12 Jun 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mikusu India Pvt Ltd12 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mikusu India Pvt Ltd12 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 1,817 Equity shares on June 09, 2026 and 11,275 Equity Shares on June 10, 2026 of Daikaffil ....11 Jun 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mikusu India Pvt Ltd10 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 8,382 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details of ....9 Jun 2026 · Company Update / General
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 6,530 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details of ....6 Jun 2026 · Company Update / General
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 6,321 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details of ....5 Jun 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mikusu India Pvt Ltd5 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mikusu India Pvt Ltd5 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Company has received disclosure from Mikusu India Private Limited informing that it has acquired 4,200 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details of ....4 Jun 2026 · Company Update / General
Enclosed herewith revised Newspaper Publication of Financial Results for the quarter and year ended March 31, 2026 due to Clerical and Typographical Errors.30 May 2026 · Company Update / Newspaper Publication
Enclosed herewith Newspaper Publication of Audited Financial Results for the quarter and year ended March 31, 2026.29 May 2026 · Company Update / Newspaper Publication
Enclosed herewith disclosure for Change in Management.28 May 2026 · Company Update / Change in Management
Enclosed herewith Audited Financial Results for the quater and year ended on March 31, 2026.28 May 2026 · Result / Financial Results
Enclosed herewith Outcome of Board Meeting.28 May 2026 · Board Meeting / Outcome of Board Meeting
Daikaffil Chemicals India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve 1. The Standalone ....22 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....17 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Board meetings

14 Aug 2026 Board Meeting - Financial Results